Evaluation of adverse effects with COVID-19 vaccination in Pakistan

被引:23
作者
Abbas, Sana [1 ]
Abbas, Beenish [3 ]
Amir, Sidra [3 ]
Wajahat, Mehreen [2 ]
机构
[1] Gwadar Dev Author Hosp, Gwadar, Pakistan
[2] Avicenna Med & Dent Coll, Lahore, Pakistan
[3] Fdn Univ, Islamabad, Pakistan
关键词
Covid-19; Vaccine; Adverse effects;
D O I
10.12669/pjms.37.7.4522
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Vaccinations work with different mechanisms to offer protection against disease; however, process of immunity building can cause symptoms. Therefore, this study aimed to determine the immediate side effects of COVID-19 vaccination in the Pakistani Population. Methods: This cross-sectional analytical study was conducted at Foundation University College of Dentistry, Islamabad from February to April 2021. 0.5 mL per dose of the Covid-19 vaccine was administered to the candidates. These 205 candidates receiving vaccination were then interviewed investigating the adverse effects of the vaccine. Post-vaccination side effects were compared among categorical groups using the Chi-Square test, whereas post-vaccination side effects were compared with age using independent samples T-test. A p-value of <= 0.05 was statistically significant. Results: Among post-vaccination side effects, fever was reported by 69 participants, while 56 of 205 reported soreness, redness, and swelling at the injection site. It was reported by 42/205 participants to have felt chills and rigor, whereas gastrointestinal disturbance and flu-like symptoms were reported in 55/205 and 28/205 participants, respectively. Younger participants were more likely to develop gastrointestinal disturbance and flu-like symptoms following vaccination as compared to older participants. Conclusion: Malaise, headache, and fever were observed to be the most common side effects of the vaccine, moreover there was a linear relationship between manifestations of adverse effects and history of comorbidities.
引用
收藏
页码:1959 / 1964
页数:6
相关论文
共 18 条
  • [1] Rituximab-related viral infections in lymphoma patients
    Aksoy, Sercan
    Harputluoglu, Hakan
    Kilickap, Saadettin
    Dede, Didem Sener
    Dizdar, Omer
    Altundag, Kadri
    Barista, Ibrahim
    [J]. LEUKEMIA & LYMPHOMA, 2007, 48 (07) : 1307 - 1312
  • [2] Bhopal S, 2020, SSRN NATURE IMMUNE R
  • [3] BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
    Dagan, Noa
    Barda, Noam
    Kepten, Eldad
    Miron, Oren
    Perchik, Shay
    Katz, Mark A.
    Hernan, Miguel A.
    Lipsitch, Marc
    Reis, Ben
    Balicer, Ran D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (15) : 1412 - 1423
  • [4] Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
    Folegatti, Pedro M.
    Ewer, Katie J.
    Aley, Parvinder K.
    Angus, Brian
    Becker, Stephan
    Belij-Rammerstorfer, Sandra
    Bellamy, Duncan
    Bibi, Sagida
    Bittaye, Mustapha
    Clutterbuck, Elizabeth A.
    Dold, Christina
    Faust, Saul N.
    Finn, Adam
    Flaxman, Amy L.
    Hallis, Bassam
    Heath, Paul
    Jenkin, Daniel
    Lazarus, Rajeka
    Makinson, Rebecca
    Minassian, Angela M.
    Pollock, Katrina M.
    Ramasamy, Maheshi
    Robinson, Hannah
    Snape, Matthew
    Tarrant, Richard
    Voysey, Merryn
    Green, Catherine
    Douglas, Alexander D.
    Hill, Adrian V. S.
    Lambe, Teresa
    Gilbert, Sarah C.
    Pollard, Andrew J.
    [J]. LANCET, 2020, 396 (10249) : 467 - 478
  • [5] Food and Drug Administration, 2020, Vitro Drug Interaction Studies: Cytochrome P450 Enzymeand Transporter-Mediated Drug Interactions Guidance for Industry, P1
  • [6] COVID-19 vaccines: where we stand and challenges ahead
    Forni, Guido
    Mantovani, Alberto
    [J]. CELL DEATH AND DIFFERENTIATION, 2021, 28 (02) : 626 - 639
  • [7] Johnson M, 2020, WHO Target Product Profiles for COVID-19 Vaccines, V10, P1
  • [8] Threat of COVID-19 Vaccine Hesitancy in Pakistan: The Need for Measures to Neutralize Misleading Narratives
    Khan, Yusra Habib
    Mallhi, Tauqeer Hussain
    Alotaibi, Nasser Hadal
    Alzarea, Abdulaziz Ibrahim
    Alanazi, Abdullah Salah
    Tanveer, Nida
    Hashmi, Furqan Khurshid
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2020, 103 (02) : 603 - 604
  • [9] SARS-CoV-2 vaccines in development
    Krammer, Florian
    [J]. NATURE, 2020, 586 (7830) : 516 - 527
  • [10] A global survey of potential acceptance of a COVID-19 vaccine
    Lazarus, Jeffrey V.
    Ratzan, Scott C.
    Palayew, Adam
    Gostin, Lawrence O.
    Larson, Heidi J.
    Rabin, Kenneth
    Kimball, Spencer
    El-Mohandes, Ayman
    [J]. NATURE MEDICINE, 2021, 27 (02) : 225 - +